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Available online 3 May 2016Background:Myotonic dystrophy type 1 (DM1) represents a multisystemic disorder in which diffuse brain white
and graymatter alterations related to clinical and genetic features have been described.We aimed to evaluate in
the brain of adult patients with DM1 (i) white and gray matter differences, including cortical-subcortical gray
matter volume and cortical thickness and (ii) their correlation with clinical disability, global neuropsychological
performance and triplet expansion.
Methods:We included 24 adult genetically-conﬁrmed DM1 patients (14 males; age: 38.5 ± 11.8 years) and 25
age- and sex-matched healthy controls (14 males; age: 38.5 ± 11.3 years) who underwent an identical brain
MRprotocol including high-resolution 3DT1-weighted, axial T2 FLAIR andDTI sequences. All patients underwent
an extensive clinical and neuropsychological evaluation. Voxel-wise analyses of white matter, performed by
using Tract Based Spatial Statistics, and of gray matter, with Voxel-based Morphometry and Cortical Thickness,
were carried out in order to test for differences between patients with DM1 and healthy controls (p b 0.05,
corrected). The correlation between MRI measures and clinical-genetic features was also assessed.
Results: Patients with DM1 showed widespread abnormalities of all DTI parameters in the white matter, which
were associated with reduced gray matter volume in all brain lobes and thinning in parieto-temporo-occipital
cortices, albeit with less extensive cortical alterations when congenital cases were removed from the analyses.
White matter alterations correlated with clinical disability, global cognitive performance and triplet expansions.
Conclusion: In patients with DM1, the combined smaller overall graymatter volume andwhitematter alterations
seem to be themainmorpho-structural substrates of CNS involvement in this condition. The correlation ofwhite
matter differences with both clinical and genetic ﬁndings lends support to this notion.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Myotonic dystrophy type 1 (DM1), also known as Steinert'smyoton-
ic dystrophy, is the most frequent inherited adult dystrophic myopathy
due to a nucleotide expansion (CTG) in the DMPK gene mapped on
chromosome 19q13.3 (Udd and Krahe, 2012). Studies regarding the
pathogenetic mechanism hypothesized an accumulation of CUG-
CCUG-containing transcripts within cell nuclei as ribonuclear inclusions
that provoke the deregulation of numerous RNAbinding factors, leadingliclinico S. Orsola – Malpighi,
BiNeM), University of Bologna,
. This is an open access article underto a dysregulation of alternative splicing of several genes encoding for
proteins and channels fundamental formuscle and Central Nervous Sys-
tem (CNS) activity (Meola and Cardani, 2015). This hypothesis is also
supported by neuropathological ﬁndings and indeed the presence of
CUG-containing RNA has been reported in DM1 cortical-subcortical
neurons (Meola and Cardani, 2015). Moreover, neuroﬁbrillary degener-
ation with intraneuronal hyperphosphorilated Tau proteins has been
reported in DM1 brain specimens (Sergeant et al., 2001; Meola and
Cardani, 2015).
Disease onset is typically in the adult age and muscle weakness,
myotonia, and cataracts represent the main clinical features, although
the disease may frequently affect other organs and systems. In particu-
lar, CNS involvement, characterized by mood and personality alter-
ations, cognitive impairment, sleep disturbances, is quite common
during disease course (Udd and Krahe, 2012; Caillet-Boudin et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(MRI) showed diffuse brain alterations in DM1 patients such as lateral
ventricle dilatation, cortical and subcortical gray matter atrophy and
leukodystrophy, prevalent in the anterior temporal lobes (Caillet-
Boudin et al., 2014).
In the last decade, advanced MRI studies demonstrated across brain
a widespread white matter disruption and amultifocal graymatter vol-
ume loss by using various single MRI techniques, including Diffusion
Tensor Imaging (DTI), and Voxel-BasedMorphometry (VBM), with cor-
relations found between corresponding quantitative MRI parameters
and triplet expansion, neuropsychological tests and the severity ofmus-
cular involvement (Antonini et al., 2004; Giorgio et al., 2006; Ota et al.,
2006; Weber et al., 2010; Minnerop et al., 2011; Wozniak et al., 2011;
Franc et al., 2012; Wozniak et al., 2013; Caso et al., 2014; Wozniak
et al., 2014; Serra et al., 2015; Schneider-Gold et al., 2015).
The aim of our study was to evaluate the extent of white and gray
matter alterations in the brain of patients with DM1 compared to
healthy controls by using multimodal voxel-wise methods, such as
TBSS, VBM and vertex-based cortical thickness (CT) analysis, and there-
fore to highlight possible correlations of these quantitative MRI mea-
sures with clinical and genetic data.
2. Materials and methods
2.1. Subjects
We enrolled 24 genetically conﬁrmed DM1 patients (14 males; age
[mean ± SD]: 38.5 ± 11.8 years; age at onset: 22.3 ± 12.8 years,
range: 0–53 years; disease duration: 16.2 ± 10.8 years, range: 1–Table 1
Demographic and clinical features of study sample.
Myotonic dystrophy 1
Age (years) (mean ± SD) 38.5 ± 11.8
Sex (M) 14
Age at onset (years) [mean ± SD (range)] 22.3 ± 12.8 (0–53)
Disease duration (years) [mean ± SD (range)] 16.2 ± 10.8 (1–36)
Education (years) (mean ± SD) 10.0 ± 2.8
CTG triplet expansion size category
E1 4
E2 13
E3 7
Clinical scale scores [median (range)]
Neuropsychological area 3 (0–16)
Motor area 11 (0−23)
Myotonia area 7 (0−12)
Daily-life activities area 2.5 (0–9)
Total score 23 (1–59)
Neuropsychological evaluation N Score (mean ± SD)
Corrected MMSE score 21 27.0 ± 2.7
BMDB ﬁnal result 20 1.6 ± 0.9
- Rey's 15 word test (short term) 20 45.8 ± 8.9
- Rey's 15 word test (long term) 20 9.8 ± 2.3
- Immediate Visual Memory test 20 17.9 ± 3.0
- Barrage Test 20 11.0 ± 2.0
- Simple analogies 20 16.4 ± 2.6
Total WAIS score 17 81.6 ± 20.6
- Verbal Intelligence score 17 83.9 ± 18.8
- Non-verbal performance score 17 82.9 ± 19.8
Verbal Fluency test 20 33.4 ± 12.8
Stroop Test (reaction time - seconds) 20 30.4 ± 22.5
Wisconsin Card Sorting Test 19
- Corrected perseverative responses 19 23.8 ± 29.7
- Corrected non-perseverative errors 19 18.3 ± 16.8
- Categories completed 19 4.2 ± 2
- Learning to learn 19 −0.6 ± 5.7
- Corrected total score 19 67.4 ± 40.1
Legend. SD: standard deviation; M: males; MMSE: Mini Mental State Examination; BMDB: Br
WCST: Wisconsin Card Sorting Test.36 years) and 25 age- and sex-matched healthy controls (14 males;
age: 38.5 ± 11.3 years). Demographic and clinical features of patients
and controls are reported in Table 1.
Patients were enrolled at the neuromuscular outpatients unit of the
U.O. Clinica Neurologica, IRCCS Istituto delle Scienze Neurologiche di
Bologna, by neurologists expert in neuromuscular disorders (RoL). Con-
trols, matched to patients for age and sex, were selected among a sam-
ple of healthy volunteers, enrolled among University and Hospital
workers and their relatives, that underwent brainMRI in order to obtain
normative values for quantitative MRI parameters for clinical and re-
search purposes.
Clinical diagnosis was genetically conﬁrmed and CTG triplet expan-
sion sizes were determined in all patients. Depending on the number
of repeat expansions, patients were divided into classes E1 (mild
phenotype, 50–150 CTG repeats), E2 (adult classical form, 150–1000
CTG repeats) or E3 (congenital disease, more than CTG 1000 repeats)
(Contardi et al., 2012).
An extensive neurological examination and a disability scale for
DM1 created by Contardi and colleagues, investigating neuropsycholog-
ical (maximum score = 20), motor (maximum score = 35), myotonia
(maximum score = 12) and daily life activity (maximum score = 15)
areas were performed in all patients, with a total score ranging from 0
(normal) to 82 (worst condition) (Contardi et al., 2012).
Moreover, all patients underwent a neuropsychological assessment
including Mini Mental State Examination (MMSE) (Folstein et al.,
1975; Measso et al., 1993), Wechsler Adult Intelligence Scale (WAIS)
3rd edition (Wechsler, 1997) with Verbal Intelligence score (VIQ) and
non-verbal performance score (PIQ), Brief Mental Deterioration Battery
(BMDB) (Gallassi et al., 1986) including Rey's 15 word test, Immediatepatients (n = 24) Controls (n = 25) p
38.5 ± 11.3 n.s.
14 n.s.
Normal values cut offs % of patients with pathological scores
N23.8 Measso et al. (1993) 9.5%
N0 Gallassi et al. (1986, 2002) 0%
N28.53 Carlesimo et al. (1996) 0%
N4.69 Carlesimo et al. (1996) 0%
N13.85 Carlesimo et al. (1996) 10.0%
N9 Carlesimo et al. (1996) 10.0%
N15.1 Gallassi et al. (1986, 2002) 20.0%
N 70 Wechsler (1997) 29.4%
N70 (Wechsler, 1997) 29.4%
N70 Wechsler (1997) 29.4%
N17.35 Carlesimo et al. (1996) 10.0%
b36.91 Caffarra et al. (2002) 20.0%
b42.60 Laiacona et al. (2000) 15.8%
b29.90 Laiacona et al. (2000) 26.3%
No cut-off
N0.00 Tarter (1973) 50.0%
b90.50 Laiacona et al. (2000) 36.8%
ief Mental Deterioration Battery; WAIS: Wechsler Adult Intelligence Scale – 3rd edition;
680 S. Zanigni et al. / NeuroImage: Clinical 11 (2016) 678–685Visual Memory (IVM) test, Barrage Test (BT) and simple analogies (SA)
test, Verbal Fluency test (Novelli et al., 1986), Stroop Test (Stroop, 1935)
andWisconsin Card Sorting Test (WCST) (Laiacona et al., 2000). All the
tests scores were normalized by correction for age and education.2.2. Brain MRI acquisition and analysis protocol
MRI scanswere acquired on a 1.5-T GE Signa scanner equippedwith
a quadrature birdcage head coil.
All patients and controls underwent a standardized brain MRI
protocol including the following sequences: a 3D high-resolution T1-
weighted fast spoiled gradient echo (FSPGR; TR = 12 ms, TE = 5 ms,
1 mm isotropic resolution), an axial T2-weighted ﬂuid-attenuated
inversion recovery (FLAIR; TE = 84.8 ms, TR = 8000 ms, 0.9375 mm
in-plane resolution, 3 mm slice thickness) and, ﬁnally, DTI (TR =
10.000 ms, TE = 87.5 ms, 25 directions, b-value = 900 mm2 s−1, axial
oblique FOV = 32 cm, 1.25 mm reconstructed in-plane resolution,
4 mm slices thickness).2.3. White matter lesions segmentation and ﬁlling
In order to quantify patients' white matter lesion load, a semi-
automatized threshold-based segmentation of white matter lesions
has been performed on T2-weighted FLAIR images by using Jim soft-
ware (Version 7.0, Xinapse Systems, Northants, UK, http://www.
xinapse.com).
For each subject T2-weighted FLAIR images were co-registered onto
T1-weighted 3D images FLIRT (Jenkinson and Smith, 2001; Jenkinson
et al., 2002), part of the Oxford FMRIB Software Library [FSL], www.
fmrib.ox.ac.uk (Smith et al., 2004) using the boundary-based registra-
tion (BBR) method and the transformation matrix was used to register
the lesion map onto the T1-weighted 3D images, applying a nearest-
neighbor interpolation method to keep the mask intact during spatial
transformation (Greve and Fischl, 2009). In order to improve the ac-
curacy of brain volumemeasurements thereafter by reducing inten-
sity contrast within known lesion areas, the FSL lesion ﬁlling tool
(Battaglini et al., 2012) was applied to the T1-weighted 3D images
using the co-registered lesion masks.2.4. TBSS analysis
DTI data underwent standard pre-processing and processing, all of
them performed with FMRIB Diffusion Toolbox (FDT part of FSL)
(Behrens et al., 2003). In particular, DTI images were corrected for
movements and distortions caused by eddy currents with a linear regis-
tration to non-diffusion volumes. After brain extraction (BET, Brain Ex-
traction Tool) (Smith, 2002), a voxel-by-voxel ﬁtting of diffusion tensor
model using dtiﬁt was performed, in order to obtain maps of fractional
anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and
mean diffusivity.
Voxelwise statistical analysis of the FA data was carried out using
TBSS (Tract-Based Spatial Statistics) (Smith et al., 2006), also part of
FSL. All subjects' FA data were aligned into a common space using the
nonlinear registration tool FNIRT (Andersson et al., 2007a,b), which
uses a b-spline representation of the registration warp ﬁeld (Rueckert
et al., 1999). Next, themean FA imagewas created and thinned to create
a mean FA skeleton, which represents the centers of all tracts common
to the group. Each subject's aligned FA data was then projected onto
this skeleton and the resulting data fed into voxelwise cross-subject sta-
tistics. FA skeleton was created by using a threshold at a value of 0.2 to
exclude voxels with low FA values, which are likely to include graymat-
ter or cerebrospinal ﬂuid (CSF). Voxelwise statistical analysis was per-
formed on AD, RD and MD data as well, by using the transformations
and the template previously obtained for FA data.2.5. Voxel-based morphometry analysis
All the gray matter structural analyses were performed on the T1-
weighted 3D images after lesion ﬁlling.
Structural datawas analyzedwith FSL-VBM(Douaud et al., 2007), an
optimized VBM protocol (Good et al., 2001) carried out with FSL tools.
First, structural images were brain-extracted and gray matter-
segmented before being registered onto the MNI 152 standard space
using non-linear registration (Andersson et al., 2007b). The resulting
images were averaged and ﬂipped along the x-axis to create a left-
right symmetric, study-speciﬁc graymatter template. Second, all native
gray matter images were non-linearly registered to this study-speciﬁc
template and “modulated” to correct for local expansion (or contrac-
tion) due to the non-linear component of the spatial transformation.
Themodulated graymatter images were then smoothedwith an isotro-
pic Gaussian kernel with a sigma of 3mm (corresponding to a FWHMof
about 7 mm).
2.6. Cortical thickness analysis
Cortical reconstruction and cortical thickness measurement were
performedwith the FreeSurfer 4.4.0 image analysis suite, and a detailed
description of preprocessing and processing is available at http://surfer.
nmr.mgh.harvard.edu/. Concisely, after skull-stripping and intensity
correction, the gray-white matter boundary for each cortical hemi-
sphere (with tissue intensity and neighborhood constraints) was iden-
tiﬁed. Then the surface boundary was tessellated to generate multiple
vertices across the whole brain, and inﬂated. The expansion of the
resulting gray matter surface created the pial surface with a point-to-
point correspondence, and spherical morphing and spherical registra-
tion to an atlas were performed. Cortical thickness was computed by
using the methods developed by Fishl and Dale (Fischl and Dale,
2000). Cortical maps were ﬁnally smoothed with a 10-mm FWHM
Gaussian kernel.
2.7. Statistical analysis
We performed a Spearman correlation test in order to evaluate the
correlation between white matter lesion volume, Total Intracranial
Volume (TIV)-corrected lateral ventricle volume and clinical-genetic
variables.
For both TBSS and VBM analyses, a voxel-wise General LinearModel
(GLM) was applied to compare DM1 group and healthy controls group
by using the FSL's tool (randomise) for nonparametric permutation in-
ference on neuroimaging data (Winkler et al., 2014), performing 5000
permutations. Results were corrected for multiple comparisons across
space, controlling the family-wise error (FWE) and applying TFCE
(threshold-free cluster enhancement) (Smith and Nichols, 2009). TBSS
comparisons were performed within a white matter skeletonized
mask (obtained during TBSS processing stream), and VBM comparisons
were performed within a gray matter mask (obtained during FSL-VBM
processing). The same method was applied to perform voxel-wise cor-
relations with clinical variables.
Vertex-by-vertex multiple linear regression analysis (surface equiv-
alent of voxel-wise analysis) was carried out to compare CT in DM1 pa-
tients and healthy controls, and to investigate the relationship between
regional CT and clinical-genetic variables, including neuropsychological
tests (corrected MMSE score, VIQ, PIQ andWAIS total score, BMDB ﬁnal
result and the corrected results of its subtests, Verbal Fluency test
corrected score, reaction time at Stroop test, WCST scores (persever-
ative responses, non-perseverative errors, categories completed,
learning to learn, global score)). Statistical maps were generated
using FreeSurfer's QDEC 1.5 (Query, Design, Estimate, Contrast)
interface. Analysis was performed over the whole brain surface and
Monte Carlo simulation was conducted to correct for multiple com-
parisons on the signiﬁcant clusters, using a cluster-wise threshold
681S. Zanigni et al. / NeuroImage: Clinical 11 (2016) 678–685of p b 0.05. As for nuisance regressors, age and sex were added for
TBSS analysis, while age, sex and total intracranial volume (TIV),
using estimated TIV from the Freesurfer processing stream, were
added for VBM and CT analysis.
Comparisonswere also performedwith a homogeneous sub-sample
of DM1patients constituted only by the classical and juvenileDM1cases
(n = 17, age (mean ± SD) 39.3 ± 12.5 years, 10 M), i.e. excluding
congenital cases (E3, n = 7), compared to a sub-group of age- and
sex-matched healthy controls (n = 17, age (mean ± SD) 39.3 ±
12.4 years, 10 M).3. Results
3.1. Clinical and genetic features
All patients, except one, who was without motor impairment,
presented muscular symptoms including myotonia (23/24 patients)
and muscle weakness (21/24 patients).
As regards genetic classiﬁcation of patients, 4 belonged to E1, 13 to
E2 and 7 to E3 classes. Mean (±standard deviation - SD) education of
caseswas 10.0± 2.8 years. The results of the sub-sections of the clinical
scale [median (range)] were 3 (0–16) for the neuropsychological area,
11 (0–23) for the motor area, 7 (0–12) for the myotonia area, 2.5 (0–
9) for the daily-life activities area with a median (range) total score of
23 (1–59) (Table 1).
In three patients out of 24, full neuropsychological evaluation was
not performed: two patients refused to undergo neuropsychological
testing while one patient's general conditions were too poor to allow
the neuropsychological assessment. Among the other 21 cases,
corrected MMSE score (mean ± SD) was 27.0 ± 2.7 with 2 cases with
a score lower than 23 (both belonging to the E3 category); ﬁnal result
of BMDB scale was 1.6 ± 0.9 with no patients displaying pathological
results (b0), and total IQ score was 81.6 ± 20.6, with 8 patients with a
score between 50 and 79 (Table 1), with ﬁve belonging to E3 and two
to E2 category. The results of the other neuropsychological tests are
reported in Table 1.Fig. 1. Tract-based spatial statistics (TBSS) group comparison results, displayed at p b 0.05 corre
(DM1) patients and healthy controls (HC) are shown for fractional anisotropy (FA; in red, decre
yellow, higher in patients) and radial diffusivity (RD; in violet, higher in patients) values. All st
mask (green). Images are shown in radiological convention.Overall, our DM1 subjects demonstrated no signiﬁcantmemory def-
icits, while the scores of the test investigating executive functions, i.e.
reasoning ability and shifting cognitive strategies (WCST), and a mean
total IQ scorewere at the lower limits of the normal range. Additionally,
motor impairment did not systematically interfere with test perfor-
mance in our sample, as can be seen from the results showing a lower
performance in the test exploring cognitive domains not related to
motor ability (i.e., WCST), and from the absence of evident discrepan-
cies between IQ verbal and performance scores.
3.2. Conventional brain MRI
No patients or controls were excluded from the analysis because of a
suboptimal quality of T2-, T1-weighted and DTI sequences. Eleven pa-
tients out of 24 showed mild to moderate cortical atrophy and/or mild
to severe lateral ventricle enlargement. Five out of 24 DM1 patients
and all control subjects showed no white matter signal alterations at
conventional brain MRI, while the other 19 showed supratentorial
white matter T2-hyperintensities with a mean lesion load of 17. 2 ±
27.5 cm3. In the 19 DM1 patients with white matter lesions, we found
a direct correlation between white matter lesion load and age at evalu-
ation (r = 0.644, p = 0.003) and an inverse correlation with corrected
MMSE score (r =−0.487, p = 0.48).
The correlation analysis between TIV-corrected lateral ventricle vol-
ume and clinical, neuropsychological and genetic features failed to yield
signiﬁcant results, after Bonferroni correction for multiple comparisons.
3.3. TBSS
White matter voxel-wise comparison performed by using TBSS
showed a widespread signiﬁcant lower FA and higher MD, AD and
RD in patients compared to controls (p b 0.05, corrected) (Fig. 1
and supplementary Tables 1.1–1.4). The TBSS analysis including
only cases in categories E1 and E2 led to similar results (supplemen-
tary Figure 1).
The analysis of the correlations among MRI-derived white matter
integrity parameters and clinical-genetic features demonstrated acted formultiple comparisons. Voxel-wise differences betweenmyotonic dystrophy type 1
ased in patients), mean diffusivity (MD; in blue, higher in patients), axial diffusivity (AD; in
atistical maps are overlaid on the group mean FA image and on the white matter skeleton
Fig. 2. Tract-based spatial statistics (TBSS) correlations results, displayed at p b 0.05 corrected formultiple comparisons. Voxel-wise correlations between fractional anisotropy (FA) values
and clinical variables inmyotonic dystrophy type 1 (DM1) patients are shown in red. The correlations are all inverse, except for FA -MMSEwhich showed a direct correlation. All statistical
maps (with tracts thickened for visualization purposes) are overlaid on the group mean FA image and on the white matter skeleton mask (green). Images are shown in radiological
convention. Legend. MMSE: Mini-Mental State Examination; NP: neuropsychological.
682 S. Zanigni et al. / NeuroImage: Clinical 11 (2016) 678–685signiﬁcant correlation between MMSE corrected score and DTI
metrics in the splenium and the posterior part of the body of the
corpus callosum (CC), posterior corona radiata and posteriorFig. 3. Voxel-basedmorphometry (VBM) group comparison results displayed at p b 0.05 correc
(DM1) patients and healthy controls are displayed with (1-p) values in red-to-white. Area
radiological convention.thalamic radiations, bilaterally and the right retrolenticular part of
the internal capsule (p b 0.05, corrected) (Fig. 2 and supplementary
Table 2.1).ted for multiple comparisons. Voxel-wise differences between myotonic dystrophy type 1
s of gray matter atrophy are overlaid on the group gray matter template and shown in
683S. Zanigni et al. / NeuroImage: Clinical 11 (2016) 678–685As regards the clinical scale, all DTImetrics in the CC (genu, body and
splenium), supero-posterior corona radiata, posterior thalamic radia-
tions, external capsule and superior longitudinal fasciculus correlated
with neuropsychological, motor, myotonia areas and with the total
score (p b 0.05, corrected) (Fig. 2 and supplementary Tables 2.2–2.5).
No correlationswere found between DTI metrics and daily life activities
area. Moreover, we found a correlation between triplet expansion size
and white matter DTI parameters, diffuse to all white matter tracts in
supra- and infratentorial compartments (p b 0.05, corrected) (Fig. 2
and supplementary Table 2.6). We found no correlation between DTI
metrics and the other neuropsychological tests. No correlation with
clinical, neuropsychological or genetic data andwhitematter disruption
was found when considering E1 and E2 cases alone.3.4. VBM
Compared to healthy controls, patients presented a bilateral signiﬁ-
cant smaller gray matter quantity in subcortical regions such as thala-
mus, hippocampus, putamen and caudate, and in cingulate, frontal,
parietal, occipital, insular and temporal cortices (p b 0.05, corrected)
(Fig. 3 and supplementary Tables 3.1–3.3). Considering patients within
genetic categories E1 and E2, VBM analysis showed a comparable
atrophy of subcortical gray matter, while cortical gray matter atrophy
was of smaller extent (supplementary Figure 2).
We found no signiﬁcant correlations of VBM results with clinical-
genetic data.3.5. Cortical thickness
Compared to controls, DM1 patients presented a signiﬁcant lower CT
in lateral-occipital cortex bilaterally, in the right precentral and in the left
superior-parietal, superior-temporal and fusiform cortices (p b 0.05,
corrected) (Fig. 4 and supplementary Table 4). The analysis performed
on E1 and E2 cases only showed a smaller cortical thickness differences
compared to controls, restricted to portions of the left fusiform, lingual
and inferior temporal gyri (supplementary Fig. 3).
No signiﬁcant correlations between CT and clinical-genetic variables
were found.Fig. 4. Group comparison results of cortical thickness (CT) analysis displayed at p b 0.05,
corrected for multiple comparisons. Whole brain vertex-wise differences of cortical
thickness between myotonic dystrophy type 1 (DM1) patients and healthy controls are
displayed with − log10(p) values. Areas of gray matter thinning are overlaid on a
reference gray matter surface; left hemisphere is shown on right and right hemisphere
on left; lateral view on top and medial view at bottom.4. Discussion
Diffuse brain white and gray matter alterations in 24 adult DM1
patients were found on conventional brain MRI and voxel-wise MRI
data analysis methods.
Nineteen out of 24 patients presented the neuroimaging hallmarks
of DM1, i.e. multiple T2-hyperintense white matter lesions associated
with different degrees of lateral ventricle enlargement, ranging from
mild to severe. Our conventional imaging data are consistent with pre-
vious studies showing brain alterations in DM1 (Antonini et al., 2004;
Giorgio et al., 2006; Ota et al., 2006; Weber et al., 2010; Minnerop
et al., 2011; Wozniak et al., 2011; Franc et al., 2012; Wozniak et al.,
2013; Caso et al., 2014; Wozniak et al., 2014; Serra et al., 2015),
although, compared to previous studies that quantiﬁed white matter
lesion load (Antonini et al., 2004; Caso et al., 2014; Serra et al., 2015),
our patients presented a more severe white matter involvement, in
absence of overall signiﬁcant cognitive deﬁcits.
Moreover, we found a correlation betweenwhitematter lesion load,
age at evaluation andMMSE corrected score. In addition, previous stud-
ies demonstrated a signiﬁcant correlation between white matter lesion
load and clinical and genetic data (Caso et al., 2014; Serra et al., 2015),
indicating that its quantiﬁcation plays a fundamental role in order to
better characterize the patient sample and to increase voxel-wise anal-
ysis accuracy.
In addition, we conﬁrmed a signiﬁcant correlation amongwhite and
gray matter disruption, assessed by TBSS, VBM and CT analysis, global
motor and cognitive functioning, and triplet expansion size.
Although previous studies evaluated gray and white matter in-
tegrity in patients with DM1 by using VBM and TBSS, and demon-
strated a correlation with clinical and genetic data (Minnerop
et al., 2011; Caso et al., 2014; Serra et al., 2015; Schneider-Gold
et al., 2015), our study is the ﬁrst in which both a CT analysis and
a VBM approach have been applied to the same group of DM1 in
order to better investigate the different contribution of CT alter-
ations and global gray matter density.
Moreover, to our knowledge, this is the ﬁrst study in patients with
DM1 that applies a semi-automatic lesion reﬁlling method before
performing both VBM and CT analysis, while a previous study applied
a fully automated lesion reﬁlling pipeline to VBM in DM1 and DM2
patients (Schneider-Gold et al., 2015). It has been demonstrated that le-
sion reﬁlling in patients with diffuse white matter alterations increases
accuracy of VBM analysis (Ceccarelli et al., 2012). The comparison
between DM1 patients and controls showed a diffuse disruption of
white matter with a correlation with genetic severity, i.e. triplet
expansion.
In addition, in order to evaluate if diffuse brain white and gray
matter alterations could inﬂuence clinical disability, we investigat-
ed the correlation between TBSS, CT analysis and VBM results and
global motor and cognitive functioning measured by a clinical
scale investigating neuropsychological, motor, myotonic symptoms
and daily life activities (Contardi et al., 2012) andMMSE, a scale that
is widely used to assess global cognitive functioning.
To our knowledge, no volumetric MR studies investigated the asso-
ciation between myotonia severity and brain alterations. Only one
fMRI study investigated CNS correlates of myotonia in 16 patients
with DM1. It was found a bigger BOLD signal in the supplementary
motor area and in the dorsal anterior cingulate cortex during myotonia
phase, suggesting a role of high-ordermotor control areas in the genesis
of this phenomenon (Toth et al., 2015). Interestingly, in our sample the
severity of myotonia correlated with a diffuse white matter alteration
involving also the posterior limb of the internal capsule, the corona
radiata adjacent to motor areas and the splenium CC (Fig. 2). White
matter differences in the same regions correlated also with the “motor
area” score of the clinical scale (Fig. 2).
In addition, cognitive performance, assessed by MMSE and the neu-
ropsychological area of the clinical scale, showed a correlation with
684 S. Zanigni et al. / NeuroImage: Clinical 11 (2016) 678–685callosal alterations, in particular in the posterior part of the body,
isthmus and splenium.
The results of our VBM analysis showed diffuse gray matter alter-
ations in DM1 patients compared to controls, involving subcortical
and cortical regions belonging to all lobes, while CT analysis showed a
prevalent involvement of parietal-occipital regions. As previously
reported, VBM analysis returns a general and mixed measure of gray
matter volume, which combines different structural properties, such
as CT, surface area and cortical folding (Hutton et al., 2008). However,
these properties are essentially independent from each other. CT analy-
sis offers a direct examination of a physical property of the cortex,
providing information about the morphometric characteristics of the
cortex. Nevertheless, CT analysis is necessarily constrained to the cortex,
while VBM can be used to detect differences in sub-cortical gray matter
aswell. It is advantageous to combine these two techniques considering
the complementary nature of the twomethods, in order to obtain more
comprehensive information about brain structure. The analyses of both
CT and VBM have been simultaneously applied to the same sample of
subjects in normal aging (Hutton et al., 2009) and other neurologic
and psychiatric diseases, such as psychosis (Benetti et al., 2013), schizo-
phrenia (Palaniyappan and Liddle, 2012), Parkinson's disease (Pereira
et al., 2012), Alzheimer's disease (Lehmann et al., 2011), major depres-
sive disorder (Koolschijn et al., 2010), autism (Hyde et al., 2010), and,
overall, consistent results between the two techniques were observed,
gaining complementary information about patterns of brain atrophy.
Taking into account these considerations, the interpretation of our
results regarding cortical gray matter integrity may be that a smaller
CT in DM1 plays a predominant role in parietal-occipital regions,
while in frontal and temporal cortices other features, such as surface
area and cortical folding,may be responsible for the alterations detected
by VBM analysis.
The alterations in posterior associative ﬁbers, i.e. splenium of CC,
posterior thalamic radiations, posterior part of corona radiata, and in
the parietal-occipital gray matter in which a decrease of gray matter
volume due principally to CTwas evident in our sample, are signiﬁcant-
ly correlated to a worse motor and cognitive performance, and may ex-
plain cognitive deﬁcits and personality alterations that are generally
described in DM1 patients. Previous studies in DM1 patients found an
association between cognitive performance and posterior associative ﬁ-
bers. In particular, posterior callosal ﬁbers, that are more resistant to
damage because theymyelinate early during brain development, are re-
lated to cognitive dysfunction (Di Paola et al., 2015). Moreover callosal
alterations have been related to personality alterations, possible due
to an altered hemispheric integration (van der Knaap and van der
Ham, 2011).
We also conﬁrmed smaller subcortical graymatter volume, in partic-
ular of hippocampus, thalamus and striate nucleus, compared to con-
trols. Previous neuropathological and neuroimaging studies detected
alterations in the basal ganglia and hippocampus (Vermersch et al.,
1996; Ota et al., 2006; Oyamada et al., 2006; Itoh et al., 2010; Weber
et al., 2010; Minnerop et al., 2011; Caso et al., 2014). These regions are
involved in motor control and cognitive functioning and their alter-
ations may contribute to the development of CNS involvement signs.
Notably, we found a correlation between clinical and genetic fea-
tureswithwhitematter disruption but not with graymatter alterations.
The clinical relevance of whitematter disruption has been seen in other
previous studies on DM1 (Minnerop et al., 2011; Caso et al., 2014) and
are suggestive of a primarily white matter involvement in DM1 with a
secondary graymatter involvement. These hypotheses are also support-
ed by the results obtained after the exclusion of cases with more severe
genetic lesions (E3), showing white matter and subcortical gray matter
alterations with milder cortical alterations. Moreover, the association
between white matter alterations and global cognitive performance,
observed when considering all genetic categories, was no longer signif-
icant after the exclusion of E3 class. Thisﬁnding is in linewith a previous
study indicating that cognitive performance is related to callosalalterations only in the congenital cases (Hashimoto et al., 1995). A
study by Giorgio and colleagues, however, showed diffuse atrophy of
the neocortex in DM1 patients without or with minimal white matter
alterations (Giorgio et al., 2006). One limitation of the study is repre-
sented by the higher educational level of controls compared to patients
that may partially explain the differences in brain structure. Although
our results showed a lower performance in a test exploring cognitive
domains that are not related to motor ability (i.e., WCST) and no dis-
crepancies between IQ verbal and performance scores were evident,
the performance of some tests included in the neuropsychological
battery, such as Stroop test, may be affected by motor impairment,
and therefore, this potential confounder has to be taken into account
when interpreting the results.
In addition, our studymay present some technical limitations, due to
the fact that the datawere collectedwithin a typical clinical framework:
lesion ﬁlling is restricted to lesions larger that 3 mm along the z direc-
tion; diffusion weighted images are characterized by low spatial resolu-
tion and non isotropic voxels; the intensity of the static magnetic ﬁeld is
relatively low (1.5 T). Despite these limitations, we believe that our
evaluation of both white matter and gray matter integrity in the same
cohort of DM1 patients, correlated with clinical and genetic aspects, is
robust and the results provide an insight into the physiopathology of
the disease.
5. Conclusions
DM1 is a multisystemic disorder in which CNS involvement,
correlated with clinical and genetic severity, is characterized by
diffuse alterations extending to all white matter tracts in supra-
and infratentorial compartments, as demonstrated by TBSS analy-
sis, and to cortical-subcortical gray matter, as evidenced by VBM
and cortical thickness analysis. Globally, our results indicate the
complexity of CNS involvement in DM1 and further longitudinal
studies are needed to clarify it.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.04.012.
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